SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 4, 2004
THE ARISTOTLE CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE 0-14669 06-116854
(State or other (Commission File Number) (IRS Employer
jurisdiction of incorporation) Identification No.)
96 Cummings Point Road, Stamford, CT 06902
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (203) 358-8000
(Former name or former address, if changed since last report)
Page 1 of 2 Pages
Page 2 of 2 Pages
Item 2.02 Results of Operations and Financial Condition.
On November 4, 2004, The Aristotle Corporation issued a press release announcing financial results for the quarter ended September 30, 2004, a copy of which is attached as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits
Exhibit 99.1 - Press release of The Aristotle Corporation, dated November 4, 2004.
The information in this Form 8-K and the Exhibit attached hereto shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, unless expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
THE ARISTOTLE CORPORATION
(Registrant)
By: /s/ H. William Smith
Name: H. William Smith
Title: Vice President, General Counsel
and Secretary
Date: November 4, 2004
EXHIBITS
Exhibit 99.1 Press release issued November 4, 2004.
For Immediate Release News Release
Contacts:
Bill Smith or Dean Johnson
The Aristotle Corporation
Phone: (203) 358-8000 or (920) 563-2446
Fax: (203) 358-0179 or (920) 563-0234
wsmith@ihc-geneve.com
int@enasco.com
The Aristotle Corporation Announces
2004 Third Quarter Results
Stamford, CT, November 4, 2004 - The Aristotle Corporation (NASDAQ: ARTL; ARTLP) announced today its results of operations for the third quarter of 2004.
For the three months ended September 30, 2004, net sales increased 6.6% to $55.4 million from $52.0 million in the third quarter of 2003. Earnings before income taxes increased 5.0% to $9.0 million from $8.6 million in the 2003 third quarter, and net earnings increased to $7.6 million compared to $5.2 million in the 2003 quarter. Net earnings applicable to common stockholders in the third quarter of 2004 was $5.5 million, or $.32 per diluted common share. In the 2003 third quarter, net earnings applicable to common stockholders was $3.1 million, or $.18 per diluted common share. Net earnings applicable to common stockholders in both the 2004 and 2003 periods includes the accretion of $2.2 million relating to the dividends on Aristotle's Series I and Series J preferred stocks issued on June 17, 2002. In each of the third quarters of 2004 and 2003, $4.3 million of preferred stock dividends were paid. Preferred stock dividends are payable, if and when declared, semi-annually on March 31 and September 30 of each year.
For the nine months ended September 30, 2004, net sales increased 6.6% to $139.0 million from $130.4 million in the first nine months of 2003. Earnings before income taxes for year-to-date 2004 increased 16.3% to $20.1 million from $17.3 million in 2003, and net earnings increased to $14.4 million from $10.5 million. Net earnings applicable to common stockholders for year-to-date 2004 was $7.9 million, or $.46 per diluted common share, compared to $4.1 million, or $.24 per diluted common share for year-to-date 2003. Net earnings applicable to common stockholders in both the 2004 and 2003 periods includes the accretion of $6.5 million relating to Aristotle's preferred stock dividends. In each of the nine-month periods of 2004 and 2003, $8.6 million of preferred stock dividends were paid.
In the quarter ended September 30, 2004, the valuation allowance that was established to reflect the estimate of Aristotle's Federal net operating tax loss carryforwards ("NOL's") that were expected to expire unutilized was reduced by $2.3 million to $8.7 million. The change in the valuation allowance related to the NOL's is predicated on the change in estimated utilization of NOL's due primarily to recent business acquisitions and other estimates of projected taxable income. In accordance with accounting principles generally accepted in the United States of America ("GAAP"), goodwill from the business acquisitions completed in the third quarter of 2004 was reduced by $.7 million and deferred tax expense decreased by $1.6 million, resulting in an increase of $.09 to diluted earnings per common share for the third quarter and nine-month periods of 2004.
Although the reported net earnings for the third quarters of 2004 and 2003 are shown after-tax, approximately $2.6 million of cash from operations was retained in Aristotle in each of the quarters as a result of the utilization of NOL's. In the nine-month periods of 2004 and 2003, approximately $5.9 million and $5.0 million, respectively, of cash from operations was retained as a result of this utilization of NOL's. Except for Federal alternative minimum tax obligations arising from limitations on the NOL's in 2004 and future years, Aristotle anticipates that the utilization of available NOL's to offset future Federal taxable income will result in Aristotle not using its cash resources to pay Federal income taxes through 2006. At September 30, 2004, the Condensed Consolidated Balance Sheet contains a net deferred tax asset of $20.2 million, net of a valuation allowance of $8.9 million, of which $8.7 million relates to the NOL's.
Steven B. Lapin, Aristotle's President and Chief Operating Officer, stated, "I am pleased to report that your Company's EBITDA for the third quarter, which includes the seasonal peak of its annual business cycle, increased 2.7% to $9.8 million compared to last year. Revenues from the Educational segment for the current quarter increased 6.7%, yielding encouraging signs that effects of troublesome state budgets are at least stabilizing, which should allow the Educational segment to return to historical growth rates. Equally encouraging is the 4.3% growth realized in revenues from the Commercial segment."
Mr. Lapin added, "With the completion of the previously announced CPR Prompt(R) and Ginsberg Scientific transactions during this quarter, Aristotle has added a variety of products that include competitive proprietary lines as well as long-proven, effective and accepted teaching aids for classrooms. Meaningful contributions are expected from each of these acquisitions as their businesses transition into your Company's broad catalog offerings. The accounting change in goodwill referred to above does not at all diminish management's evaluation of the businesses acquired."
Dean T. Johnson, Aristotle's Chief Financial Officer, noted, "Your Company continues to maintain a strong financial position as reported by the balance sheet as of September 30, 2004. Including the cash investment of approximately $3.7 million for the acquisitions made in this quarter, long-term debt is $8.5 million less than at September 30, 2003. In addition to servicing the preferred stock dividends as well as the acquisitions, cash generated from operations has been used to reduce long-term debt to strategically favorable levels. At the same time, your Company maintained a favorable ratio of current assets to current liabilities of 4.8 to 1."
In providing EBITDA information, Aristotle offers a non-GAAP financial measure to complement its condensed consolidated financial statements presented in accordance with GAAP. This non-GAAP financial measure is intended to supplement the reader's overall understanding of Aristotle's current financial performance. However, this non-GAAP financial measure is not intended to supercede or replace Aristotle's GAAP results. A reconciliation of the non-GAAP results to the GAAP results is provided in the "Reconciliation of GAAP Net Earnings to EBITDA" schedule below. EBITDA is defined as earnings before interest and other income, income taxes, depreciation and amortization.
About Aristotle
The Aristotle Corporation, founded in 1986, and headquartered in Stamford, CT, is a leading manufacturer and global distributor of educational, health, medical technology and agricultural products. A selection of over 80,000 items is offered, primarily through 47 separate catalogs carrying the brand of Nasco (founded in 1941), as well as those bearing the brands of Life/Form(R), Whirl-Pak(R), Simulaids, Triarco, Summit Learning, Hubbard Scientific, Scott Resources, Spectrum Educational Supplies, Haan Crafts, To-Sew, CPR Prompt(R) and Ginsberg Scientific. Products include educational materials and supplies for substantially all K-12 curricula, molded plastics, biological materials, medical simulators and items for the agricultural, senior care and food industries. Aristotle has approximately 800 employees at its operations in Fort Atkinson, WI, Modesto, CA, Fort Collins, CO, Plymouth, MN, Woodstock, NY, Chippewa Falls, WI, Otterbein, IN and Newmarket, Ontario, Canada.
There are approximately 17.1 million shares outstanding of Aristotle common stock (NASDAQ: ARTL) and approximately 1.1 million shares outstanding of 11%, cumulative, convertible, voting, Series I preferred stock (NASDAQ: ARTLP); there are also approximately 11.0 million privately-held shares outstanding of 12%, cumulative, non-convertible, non-voting shares of Series J preferred stock. Aristotle has about 4,000 shareholders of record.
Further information about Aristotle can be obtained on its website, at
www.aristotlecorp.net.Safe Harbor under the Private Securities Litigation Reform Act of 1995
To the extent that any of the statements contained in this release are forward-looking, such statements are based on current expectations that involve a number of uncertainties and risks. Aristotle cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including, but not limited to, the following: (i) the ability of Aristotle to obtain financing and additional capital to fund its business strategy on acceptable terms, if at all; (ii) the ability of Aristotle on a timely basis to find, prudently negotiate and consummate additional acquisitions; (iii) the ability of Aristotle to manage any to-be acquired businesses; (iv) the ability of Aristotle to retain and utilize its Federal net operating tax loss carryforward position; and (v) general economic conditions. As a result, Aristotle's future development efforts involve a high degree of risk. For further information, please see Aristotle's filings with the Securities and Exchange Commission, including its Forms 10-K, 10-Q and 8-K.
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except share and per share data)
(Unaudited)
|
Three Months Ended |
Nine Months Ended |
||||||||||||||||||
September 30, |
September 30, |
|||||||||||||||||||
2004 |
2003 |
2004 |
2003 |
|||||||||||||||||
Net sales |
$ |
55,368 |
51,953 |
139,000 |
130,355 |
|||||||||||||||
Cost of sales |
35,199 |
32,592 |
86,811 |
81,529 |
||||||||||||||||
Gross profit |
20,169 |
19,361 |
52,189 |
48,826 |
||||||||||||||||
Selling and administrative expense |
10,885 |
10,319 |
31,170 |
30,437 |
||||||||||||||||
Earnings from operations |
9,284 |
9,042 |
21,019 |
18,389 |
||||||||||||||||
Other expense (income): |
||||||||||||||||||||
Interest expense |
292 |
452 |
894 |
1,131 |
||||||||||||||||
Other, net |
(41) |
(10) |
(20) |
(65) |
||||||||||||||||
251 |
442 |
874 |
1,066 |
|||||||||||||||||
Earnings before income taxes |
9,033 |
8,600 |
20,145 |
17,323 |
||||||||||||||||
Income taxes: |
||||||||||||||||||||
Current |
1,004 |
821 |
2,038 |
1,800 |
||||||||||||||||
Deferred |
411 |
2,572 |
3,686 |
5,018 |
||||||||||||||||
1,415 |
3,393 |
5,724 |
6,818 |
|||||||||||||||||
Net earnings |
7,618 |
5,207 |
14,421 |
10,505 |
||||||||||||||||
Preferred dividends |
2,158 |
2,150 |
6,479 |
6,450 |
||||||||||||||||
Net earnings applicable to common stockholders |
$ |
5,460 |
3,057 |
7,942 |
4,055 |
|||||||||||||||
Earnings per common share: |
||||||||||||||||||||
Basic |
$ |
.32 |
.18 |
.46 |
.24 |
|||||||||||||||
Diluted |
$ |
.32 |
.18 |
.46 |
.24 |
|||||||||||||||
Weighted average common shares outstanding: |
||||||||||||||||||||
Basic |
17,120,573 |
17,033,069 |
17,110,431 |
17,032,153 |
||||||||||||||||
Diluted |
17,330,679 |
17,206,851 |
17,298,250 |
17,164,339 |
RECONCILIATION OF GAAP NET EARNINGS TO EBITDA
(in thousands)
(unaudited)
Three Months Ended |
Nine Months Ended |
|||||||||
September 30, |
September 30, |
|||||||||
2004 |
2003 |
2004 |
2003 |
|||||||
Net earnings |
$ |
7,618 |
5,207 |
14,421 |
10,505 |
|||||
Add: |
||||||||||
Income taxes |
1,415 |
3,393 |
5,724 |
6,818 |
||||||
Interest expense and other income |
251 |
442 |
874 |
1,066 |
||||||
Depreciation and amortization |
488 |
478 |
1,348 |
1,336 |
||||||
EBITDA |
$ |
9,772 |
9,520 |
22,367 |
19,725 |
THE ARISTOTLE CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
Assets |
September 30, 2004 |
December 31, 2003 |
September 30, 2003 |
|||||
(unaudited) |
(unaudited) |
|||||||
Current assets: |
||||||||
Cash and cash equivalents Investments |
$ |
4,219 1,016 |
5,566 - |
7,058 - |
||||
Accounts receivable, net |
23,070 |
11,881 |
22,109 |
|||||
Inventories |
33,348 |
29,157 |
29,804 |
|||||
Prepaid expenses and other |
3,912 |
5,598 |
5,777 |
|||||
Refundable income taxes |
- |
344 |
- |
|||||
Deferred income taxes |
9,292 |
8,184 |
7,251 |
|||||
Total current assets |
74,857 |
60,730 |
71,999 |
|||||
Property, plant and equipment, net |
17,256 |
17,340 |
16,855 |
|||||
Goodwill |
13,530 |
11,509 |
10,908 |
|||||
Deferred income taxes |
10,952 |
15,081 |
16,743 |
|||||
Other assets |
526 |
454 |
321 |
|||||
Total assets |
$ |
117,121 |
105,114 |
116,826 |
||||
Liabilities and Stockholders' Equity |
||||||||
Current liabilities: |
||||||||
Current installments of long-term debt |
$ |
105 |
1,415 |
1,541 |
||||
Trade accounts payable |
9,320 |
5,874 |
8,889 |
|||||
Accrued expenses |
5,981 |
4,537 |
4,148 |
|||||
Accrued dividends payable |
- |
2,154 |
- |
|||||
Income taxes |
245 |
- |
680 |
|||||
Total current liabilities |
15,651 |
13,980 |
15,258 |
|||||
Long-term debt, less current installments |
32,880 |
31,290 |
41,356 |
|||||
Stockholders' equity: |
||||||||
Preferred stock, Series I |
6,580 |
6,412 |
6,319 |
|||||
Preferred stock, Series J |
65,760 |
65,760 |
65,760 |
|||||
Common stock |
171 |
171 |
170 |
|||||
Additional paid-in capital |
1,288 |
860 |
668 |
|||||
Accumulated deficit |
(5,315) |
(13,257) |
(12,569) |
|||||
Accumulated other comprehensive earnings (loss) |
106 |
(102) |
(136) |
|||||
Total stockholders' equity |
68,590 |
59,844 |
60,212 |
|||||
Total liabilities and stockholders' equity |
$ |
117,121 |
105,114 |
116,826 |